Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
M Rosellini, A Marchetti, V Mollica, A Rizzo… - Nature Reviews …, 2023 - nature.com
The therapeutic algorithm of renal cell carcinoma has been revolutionized by the approval of
immunotherapy agents by regulatory agencies. However, objective and durable responses …
immunotherapy agents by regulatory agencies. However, objective and durable responses …
miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses
Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
A novel cuproptosis-related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma
Z Bian, R Fan, L Xie - Genes, 2022 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of renal cell
carcinoma, which is characterized by metabolic reprogramming. Cuproptosis, a novel form …
carcinoma, which is characterized by metabolic reprogramming. Cuproptosis, a novel form …
HO‐1 contributes to luteolin‐triggered ferroptosis in clear cell renal cell carcinoma via increasing the labile iron pool and promoting lipid peroxidation
S Han, F Lin, Y Qi, C Liu, L Zhou, Y Xia… - Oxidative Medicine …, 2022 - Wiley Online Library
Ferroptosis, a novel form of regulated cell death characterized by disrupted iron metabolism
and the accumulation of lipid peroxides, has exhibited enormous potential in the therapy of …
and the accumulation of lipid peroxides, has exhibited enormous potential in the therapy of …
[HTML][HTML] Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …
LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma
Background Distant metastasis is the major cause of clear cell renal cell carcinoma (ccRCC)-
associated mortality. However, molecular mechanisms involved in ccRCC metastasis …
associated mortality. However, molecular mechanisms involved in ccRCC metastasis …
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review
AKA Lalani, DYC Heng, NS Basappa… - Therapeutic …, 2022 - journals.sagepub.com
Background: Renal cell carcinoma (RCC) is a common malignancy with approximately 30%
of cases diagnosed at the advanced or metastatic stage. While single-agent vascular …
of cases diagnosed at the advanced or metastatic stage. While single-agent vascular …
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases
X Yin, Y Chen, R Ruze, R Xu, J Song… - Signal Transduction and …, 2022 - nature.com
The incidence of metabolism-related diseases like obesity and type 2 diabetes mellitus has
reached pandemic levels worldwide and increased gradually. Most of them are listed on the …
reached pandemic levels worldwide and increased gradually. Most of them are listed on the …
Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the …
J Hao, Q Chen, Y Feng, Q Jiang, H Sun, B Deng… - Cell Death & …, 2023 - nature.com
Ferroptosis, a nonapoptotic form of programmed cell death characterized by significant iron-
dependent peroxidation of phospholipids, is regulated by cellular metabolism, redox …
dependent peroxidation of phospholipids, is regulated by cellular metabolism, redox …
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy
Clear cell renal cell carcinoma (ccRCC) is a heterogeneous tumor with different genetic and
molecular alterations. Schemes for ccRCC classification system based on multiomics are …
molecular alterations. Schemes for ccRCC classification system based on multiomics are …